Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

876 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trial.
Paolini JF, Mitchel YB, Reyes R, Thompson-Bell S, Yu Q, Lai E, Watson DJ, Norquist JM, Sisk CM, Bays HE. Paolini JF, et al. Among authors: reyes r. Int J Clin Pract. 2008 Jun;62(6):896-904. doi: 10.1111/j.1742-1241.2008.01739.x. Epub 2008 Apr 10. Int J Clin Pract. 2008. PMID: 18410350 Free PMC article. Clinical Trial.
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
Maccubbin D, Bays HE, Olsson AG, Elinoff V, Elis A, Mitchel Y, Sirah W, Betteridge A, Reyes R, Yu Q, Kuznetsova O, Sisk CM, Pasternak RC, Paolini JF. Maccubbin D, et al. Among authors: reyes r. Int J Clin Pract. 2008 Dec;62(12):1959-70. doi: 10.1111/j.1742-1241.2008.01938.x. Int J Clin Pract. 2008. PMID: 19166443 Clinical Trial.
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR; Ezetimibe Study Group. Bays HE, et al. Among authors: reyes r. Clin Ther. 2004 Nov;26(11):1758-73. doi: 10.1016/j.clinthera.2004.11.016. Clin Ther. 2004. PMID: 15639688 Clinical Trial.
A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet.
Ose L, Johnson-Levonas A, Reyes R, Lin J, Shah A, Tribble D, Musliner T; Vytorin Extension Study Group. Ose L, et al. Among authors: reyes r. Int J Clin Pract. 2007 Sep;61(9):1469-80. doi: 10.1111/j.1742-1241.2007.01402.x. Epub 2007 Jul 26. Int J Clin Pract. 2007. PMID: 17655686 Clinical Trial.
Effects of alendronate on gastric and duodenal mucosa.
Lanza F, Rack MF, Simon TJ, Lombardi A, Reyes R, Suryawanshi S. Lanza F, et al. Among authors: reyes r. Am J Gastroenterol. 1998 May;93(5):753-7. doi: 10.1111/j.1572-0241.1998.219_a.x. Am J Gastroenterol. 1998. PMID: 9625122 Clinical Trial.
Meta-analysis: budesonide treatment for collagenous colitis.
Feyen B, Wall GC, Finnerty EP, DeWitt JE, Reyes RS. Feyen B, et al. Among authors: reyes rs. Aliment Pharmacol Ther. 2004 Oct 1;20(7):745-9. doi: 10.1111/j.1365-2036.2004.02164.x. Aliment Pharmacol Ther. 2004. PMID: 15379834 Free article.
876 results